文献速递类风湿关节炎

抗II型胶原抗体与急性起病类风湿关节炎表型相关并预示5年随访炎症程度较低

Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
PubMed 文献 · Ann Rheum Dis · 2017-03-23

该研究在773例瑞典类风湿关节炎(RA)患者中检测基线抗II型胶原(anti-CII)抗体和抗CCP2抗体,并随访5年临床数据及HLA-DRB1*等位基因。结果显示anti-CII阳性与诊断时及6个月内炎症指标升高相关,但随时间改善,且更常达到EULAR良好或中等反应;anti-CCP2则与6个月后关节肿胀和DAS28恶化相关。anti-CII与HLA-DRB1*01和*03正相关,吸烟者anti-CII水平较低。

要点

  • anti-CII阳性RA表现为早期炎症活跃但5年内炎症改善的急性起病表型。
  • anti-CII与HLA-DRB1*01和*03正相关,双阳性者anti-CII水平显著更高。
  • anti-CII阳性患者更常达到EULAR良好或中等反应,但抗体检测不用于诊断。

核心结论

  • anti-CII血清阳性RA代表一种独特表型,早期anti-CII检测可预测较好的炎症结局。

研究设计与样本

  • 基于瑞典EIRA研究的773例RA患者,基线检测anti-CII和anti-CCP2,其中1476例有HLA-DRB1*信息,随访5年临床数据来自SRQ登记。

主要发现

  • anti-CII与诊断时及6个月内的CRP、ESR、SJC、DAS28和DAS28CRP升高相关。
  • anti-CCP2与6个月至5年的SJC和DAS28相关,但早期不相关。
  • anti-CII与CRP、ESR、SJC、TJC和DAS28的改善相关,而anti-CCP2与SJC和DAS28随时间恶化相关。
  • anti-CII阳性患者更常达到EULAR良好或中等反应。
  • anti-CII与HLA-DRB1*01和*03正相关且有显著交互作用,双阳性个体平均anti-CII水平比HLA双阴性者高14倍以上;吸烟者anti-CII水平较低。

关键数值与推荐

  • anti-CII阳性与诊断时及6个月内CRP、ESR、SJC、DAS28和DAS28CRP升高相关。
  • anti-CCP2与6个月至5年的SJC和DAS28相关。
  • anti-CII阳性患者达到EULAR良好或中等反应的比例高于阴性患者。
  • HLA-DRB1*01和*03双阳性个体平均anti-CII水平比HLA双阴性者高14倍以上。

临床怎么用

  • 早期检测anti-CII有助于识别预后较好、炎症可能自行改善的RA亚型。
  • anti-CII阳性RA患者可能更易达到EULAR良好或中等反应。
  • anti-CII不用于RA诊断,但可作为预后参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Antifibrillar collagen type II (anti-CII) antibody-positive patients with rheumatoid arthritis (RA) have early but not late signs of increased inflammation and joint erosions. We wanted to replicate this in a large RA cohort, and to relate to human leukocyte antigen (HLA)-DRB1* alleles. METHODS: Anti-CII and anti-cyclic citrullinated peptide (CCP)2 were measured at baseline in 773 patients with RA from the Swedish Epidemiological Investigation in Rheumatoid Arthritis (EIRA) study with clinical follow-up data from the Swedish Rheumatology Quality Register (SRQ) registry, and 1476 with HLA-DRB1* information. Comparisons were done concerning C reactive protein (CRP), erythrocyte sedimentation rate (ESR), tender joint count (TJC), swollen joint count (SJC), Disease Activity Score encompassing 28 joints based on ESR (DAS28), DAS28CRP, pain-Visual Analogue Scale (VAS), global-VAS and Health Assessment Questionnaire Score (HAQ) at eight occasions during 5 years, and association with HLA-DRB1* alleles. RESULTS: Anti-CII associated with elevated CRP, ESR, SJC, DAS28 and DAS28CRP at diagnosis and up to 6 months, whereas anti-CCP2 associated with SJC and DAS28 from 6 months to 5 years, but not earlier. The anti-CII-associated phenotype was strong, and predominated in anti-CII/anti-CCP2 double-positive patients. Anti-CII was associated with improvements in CRP, ESR, SJC, TJC and DAS28, whereas anti-CCP2 was associated with deteriorations in SJC and DAS28 over time. Anti-CII-positive patients achieved European League Against Rheumatism good or moderate response more often than negative patients. Anti-CII was positively associated with HLA-DRB1*01 and HLA-DRB1*03, with significant interaction, and double-positive individuals had >14 times higher mean anti-CII levels than HLA double negatives. Whereas smoking was associated with elevated anti-CCP2 levels, smokers had lower anti-CII levels. CONCLUSIONS: Anti-CII seropositive RA represents a distinct phenotype, in many respects representing the converse to the clinical, genetic and smoking associations described for anticitrullinated protein peptide autoantibodies. Although not diagnostically useful, early anti-CII determinations predict favourable inflammatory outcome in RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Manivel VA, Mullazehi M, Padyukov L, et al. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up. Ann Rheum Dis. 2017. PMID: 28336519. doi:10.1136/annrheumdis-2016-210873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。